Crossmark

Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial

Crossref DOI link: https://doi.org/10.1016/j.rmed.2013.11.009

Published Print: 2014-01

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Lötvall, Jan

Bleecker, Eugene R.

Busse, William W.

O'Byrne, Paul M.

Woodcock, Ashley

Kerwin, Edward M.

Stone, Sally

Forth, Richard

Jacques, Loretta

Bateman, Eric D.
Funding

Funding for this research was provided by:

GlaxoSmithKline
License Information

Text and Data Mining valid from 2014-01-01

Text and Data Mining valid from 2014-01-01

Version of Record valid from 2013-11-14
More Information

This article is maintained by: Elsevier

Article Title: Efficacy and safety of fluticasone furoate 100 μg once-daily in patients with persistent asthma: A 24-week placebo and active-controlled randomised trial

Journal Title: Respiratory Medicine

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.rmed.2013.11.009

Content Type: article

Copyright: Copyright © 2013 The Authors. Published by Elsevier Ltd.

Updates are available Erratum dated 2015-01-01

Click to view Erratum: https://doi.org/10.1016/j.rmed.2014.10.014